PT  - JOURNAL ARTICLE
AU  - Parry, Nicola
ED  - Ridderstråle, Martin
TI  - Empagliflozin Superior to Glimepiride as Second-line Treatment in T2DM
DP  - 2014 Dec 01
TA  - MD Conference Express
PG  - 12--13
VI  - 14
IP  - 32
4099  - http://mdc.sagepub.com/content/14/32/12.short
4100  - http://mdc.sagepub.com/content/14/32/12.full
AB  - Empagliflozin is superior to glimepiride as an add-on treatment option for patients with type 2 diabetes mellitus who have not achieved good glycemic control on metformin, according to results from the Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes trial that are presented in this article.